Combining medical with business
Why this blog today? To emphasize what lab medicine needs, i.e., a holistic approach from a holistic viewpoint to solve the current problems we are facing. Using technology, with a business mindset to help patients. The other week I was honored to present my use case, a holistic approach from a holistic viewpoint “AI tools in […]
Hello 2024!
May 2024 be wonderful! Wow, 2023 has been quite a year personally and professionally. Just like most of us, I use this last week of 2023 to reflect, personally and professionally. This year professionally includes my own business, focusing on precision medicine, digital pathology and regulatory science. Having our SolarisRTC team grown and evolve, we […]
Tell me, why again?
Why do we do what we do? Last week I attended the Personalized Medicine Coalition (PMC) conference. I ENJOYED it. The line up of presenters, panels and contents was perfect. Discussions about politics, investments, return on investment, latest device and treatment developments and their trends, and its influence on current and future healthcare AND how […]
We Build A Strong Foundation
When you say Orlando, you think Disney, Universal…I think Pathology Visions! Last week it was Halloween weekend, and it didn’t go unnoticed at the Pathology Visions conference…walking to the conference, we had to pass a spooky event. Many spooky costumes, masks, puppets,…People invested a lot of efforts in dressing up and it was impressive to […]
Proposed LDT Rule and Patient Considerations
The LDT rule. I am going to keep this blog brief, because there are many posts on several media already, all with many thoughts and considerations. What I blog about today, is looking at it from patient perspective. As FDA points out in their proposed rule (PR), “an LDT to be an IVD that is […]
Digital Pathology is here to stay
Before start reading my blog, answer this question please:What drives patient management? Before providing my response to this question, let me start with sharing my statement, then with explaining the reasons behind my statement, providing my perspective response to the question and conclude with next steps. Statement:Digital pathology (DP) is here to stay.I am stating […]
…High on the agenda? Difficult? Important? Necessary?
… High on the agenda? Difficult? Important? Necessary? These are some examples of the unpublished words of the question “Why is interoperability so…?” of my previous blog. The answer to all these? Because it brings value to whom needs it! Yes, unfortunately it is also the answer to the question why interoperability is so difficult. […]
Why is interoperability so…?
Since I started in digital pathology in 2011, I noticed that interoperability has been on the agenda. It has always been prioritized because it is a high need to advance health care. And yet, here we are: still on the agenda, still being prioritized. Are we making progress? Today I would like to address interoperability […]
From Volume Based to Value Based Care
From volume based to value based care. This is what we hear. This is what we wish for our patients, this is what we want for our loved ones, for ourselves. Why then is it not happening? Today I am going to blog about reimbursement of diagnostic tests in the USA. I believe reimbursement can […]
FDA Pilot Program Lab Developed Companion Diagnostics
Today the FDA published a pilot program using minimal performance criteria for companion diagnostics. When reading it, I regard this could benefit patients and labs. FDA seems to be looking into no more one-drug-one test using minimal performance criteria. I certainly applaud this; it’s about care and well-being of patients. Reading the guidance, it seems […]
